Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Middleton

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
British Journal of Cancer|August 30, 2008
Association of early life factors and brain tumour risk in a cohort studyM M Cantwell, M R Forman, R J Middleton, et al.
The British Journal of Dermatology|February 18, 2003
Audit of basal cell carcinoma: registration practiceN M McLoone, R J Middleton, A T Gavin, et al.
Irish Medical Journal|December 5, 2003
Lung cancer survival in Northern IrelandA T Gavin, P Wilkinson, D A Fitzpatrick, et al.
QJM : Monthly Journal of the Association of Physicians|July 2, 2013
Associations of baseline characteristics with evolution of eGFR in a referred chronic kidney disease cohortR A Hoefield, P A Kalra, B Lane, et al.
Kidney International|January 6, 2006
MR-derived renal morphology and renal function in patients with atherosclerotic renovascular diseaseC M Cheung, A E Shurrab, D L Buckley, et al.
BJU International|March 31, 2004
Evidence of prostate cancer screening in a UK regionA Gavin, P McCarron, R J Middleton, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|September 19, 2006
Time to move from serum creatinine to eGFRJ P New, D J O'Donoghue, R J Middleton, et al.
QJM : Monthly Journal of the Association of Physicians|February 10, 2009
Proteinuria as a predictor of renal functional outcome after revascularization in atherosclerotic renovascular disease (ARVD)C Chrysochou, C M Cheung, M Durow, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 6, 2007
Assessing the prevalence, monitoring and management of chronic kidney disease in patients with diabetes compared with those without diabetes in general practiceJ P New, R J Middleton, B Klebe, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 9, 2004
Quantitative analysis of the formation and diffusion of A1-adenosine receptor-antagonist complexes in single living cellsS J Briddon, R J Middleton, Y Cordeaux, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
British Journal of Cancer|August 30, 2008
Association of early life factors and brain tumour risk in a cohort studyM M Cantwell, M R Forman, R J Middleton, et al.
The British Journal of Dermatology|February 18, 2003
Audit of basal cell carcinoma: registration practiceN M McLoone, R J Middleton, A T Gavin, et al.
Irish Medical Journal|December 5, 2003
Lung cancer survival in Northern IrelandA T Gavin, P Wilkinson, D A Fitzpatrick, et al.
QJM : Monthly Journal of the Association of Physicians|July 2, 2013
Associations of baseline characteristics with evolution of eGFR in a referred chronic kidney disease cohortR A Hoefield, P A Kalra, B Lane, et al.
Kidney International|January 6, 2006
MR-derived renal morphology and renal function in patients with atherosclerotic renovascular diseaseC M Cheung, A E Shurrab, D L Buckley, et al.
BJU International|March 31, 2004
Evidence of prostate cancer screening in a UK regionA Gavin, P McCarron, R J Middleton, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|September 19, 2006
Time to move from serum creatinine to eGFRJ P New, D J O'Donoghue, R J Middleton, et al.
QJM : Monthly Journal of the Association of Physicians|February 10, 2009
Proteinuria as a predictor of renal functional outcome after revascularization in atherosclerotic renovascular disease (ARVD)C Chrysochou, C M Cheung, M Durow, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 6, 2007
Assessing the prevalence, monitoring and management of chronic kidney disease in patients with diabetes compared with those without diabetes in general practiceJ P New, R J Middleton, B Klebe, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 9, 2004
Quantitative analysis of the formation and diffusion of A1-adenosine receptor-antagonist complexes in single living cellsS J Briddon, R J Middleton, Y Cordeaux, et al.
Pageof 3